Combination treatment of ligustrazine piperazine derivate DLJ14 and adriamycin inhibits progression of resistant breast cancer through inhibition of the EGFR/PI3K/Akt survival pathway and induction of apoptosis (Q35125067)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combination treatment of ligustrazine piperazine derivate DLJ14 and adriamycin inhibits progression of resistant breast cancer through inhibition of the EGFR/PI3K/Akt survival pathway and induction of apoptosis |
scientific article |
Statements
1 reference
Combination treatment of ligustrazine piperazine derivate DLJ14 and adriamycin inhibits progression of resistant breast cancer through inhibition of the EGFR/PI3K/Akt survival pathway and induction of apoptosis (English)
1 reference
Jinhua Chen
1 reference
Wenfang Wang
1 reference
Hongyuan Wang
1 reference
Xinyong Liu
1 reference
Xiuli Guo
1 reference
1 February 2014
1 reference
1 reference
8
1 reference
1
1 reference
33-41
1 reference
Identifiers
1 reference
1 reference